Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cryptosporidiosis: early-phase trial registry
1 of 4 indexed Cryptosporidiosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Cryptosporidiosis: 4 US clinical trials tracked, 1 recruiting.
Cryptosporidiosis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Janssen, running 1 of these trials.
Enrollment posture brief
Registry condition cryptosporidiosis
OPEN 1 | RECR 25% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Cryptosporidiosis lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cryptosporidiosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cryptosporidiosis is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Novartis Pharmaceuticals
NCT07249463
A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001081
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
Pfizer
NCT00002082
A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
Janssen
NCT00002278
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cryptosporidiosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cryptosporidiosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cryptosporidiosis page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cryptosporidiosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Janssen sponsors the most Cryptosporidiosis trials on record, review their full trial history before evaluating a specific study. See Janssen's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cryptosporidiosis condition card totals 4 registered trials; most-linked intervention Diclazuril; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.